Suppr超能文献

ErbB3(HER3)受体蛋白的蛋白酪氨酸激酶同源结构域的生化特性

Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

作者信息

Sierke S L, Cheng K, Kim H H, Koland J G

机构信息

Department of Pharmacology, University of Iowa College of Medicine, Iowa City, IA 52242, USA.

出版信息

Biochem J. 1997 Mar 15;322 ( Pt 3)(Pt 3):757-63. doi: 10.1042/bj3220757.

Abstract

The putative protein tyrosine kinase domain (TKD) of the ErbB3 (HER3) receptor protein was generated as a histidine-tagged recombinant protein (hisTKD-B3) and characterized enzymologically. CD spectroscopy indicated that the hisTKD-B3 protein assumed a native conformation with a secondary structure similar to that of the epidermal growth factor (EGF) receptor TKD. However, when compared with the EGF receptor-derived protein, hisTKD-B3 exhibited negligible intrinsic protein tyrosine kinase activity. Immune complex kinase assays of full-length ErbB3 proteins also yielded no evidence of catalytic activity. A fluorescence assay previously used to characterize the nucleotide-binding properties of the EGF receptor indicated that the ErbB3 protein was unable to bind nucleotide. The hisTKD-B3 protein was subsequently found to be an excellent substrate for the EGF receptor protein tyrosine kinase, which suggested that in vivo phosphorylation of ErbB3 in response to EGF could be attributed to a direct cross-phosphorylation by the EGF receptor protein tyrosine kinase.

摘要

ErbB3(HER3)受体蛋白的假定蛋白酪氨酸激酶结构域(TKD)作为组氨酸标签重组蛋白(hisTKD-B3)产生,并进行了酶学表征。圆二色光谱表明,hisTKD-B3蛋白呈现出与表皮生长因子(EGF)受体TKD二级结构相似的天然构象。然而,与源自EGF受体的蛋白相比,hisTKD-B3表现出可忽略不计的内在蛋白酪氨酸激酶活性。全长ErbB3蛋白的免疫复合物激酶测定也未产生催化活性的证据。先前用于表征EGF受体核苷酸结合特性的荧光测定表明,ErbB3蛋白无法结合核苷酸。随后发现hisTKD-B3蛋白是EGF受体蛋白酪氨酸激酶的优良底物,这表明体内ErbB3对EGF的磷酸化可能归因于EGF受体蛋白酪氨酸激酶的直接交叉磷酸化。

相似文献

2
Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein.
Gene. 1995 Nov 20;165(2):279-84. doi: 10.1016/0378-1119(95)00436-a.
3
Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
Biochem J. 1998 Aug 15;334 ( Pt 1)(Pt 1):189-95. doi: 10.1042/bj3340189.
4
ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.
Biochem J. 1998 Aug 1;333 ( Pt 3)(Pt 3):757-63. doi: 10.1042/bj3330757.
5
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.
Mol Cell Biol. 1994 Jun;14(6):3550-8. doi: 10.1128/mcb.14.6.3550-3558.1994.
9
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Mol Cell Biol. 1986 May;6(5):1729-40. doi: 10.1128/mcb.6.5.1729-1740.1986.
10
NDF/heregulin stimulates the phosphorylation of Her3/erbB3.
FEBS Lett. 1994 Jul 25;349(1):139-43. doi: 10.1016/0014-5793(94)00644-x.

引用本文的文献

1
Emerging importance of HER3 in tumorigenesis and cancer therapy.
Nat Rev Clin Oncol. 2025 May;22(5):348-370. doi: 10.1038/s41571-025-01008-y. Epub 2025 Mar 14.
2
PlexinD1 is a driver and a therapeutic target in advanced prostate cancer.
EMBO Mol Med. 2025 Feb;17(2):336-364. doi: 10.1038/s44321-024-00186-z. Epub 2025 Jan 2.
3
HER4 is a high-affinity dimerization partner for all EGFR/HER/ErbB family proteins.
Protein Sci. 2024 Oct;33(10):e5171. doi: 10.1002/pro.5171.
4
Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13).
Cancer Res Treat. 2024 Oct;56(4):1136-1145. doi: 10.4143/crt.2023.1324. Epub 2024 Apr 29.
6
The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer.
Front Physiol. 2024 Mar 27;15:1358850. doi: 10.3389/fphys.2024.1358850. eCollection 2024.
7
Embryonic lethality and defective mammary gland development of activator-function impaired conditional knock-in mice.
Adv Genet (Hoboken). 2020 Dec 5;2(1):e10036. doi: 10.1002/ggn2.10036. eCollection 2021 Mar.
9
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer.
Cancer J. 2022;28(5):339-345. doi: 10.1097/PPO.0000000000000622.
10
Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors.
Chem Rev. 2022 Sep 14;122(17):13952-13988. doi: 10.1021/acs.chemrev.1c01035. Epub 2022 Jun 17.

本文引用的文献

2
Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.
J Biol Chem. 1996 Aug 9;271(32):19029-32. doi: 10.1074/jbc.271.32.19029.
7
Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein.
Gene. 1995 Nov 20;165(2):279-84. doi: 10.1016/0378-1119(95)00436-a.
8
A self-consistent method for the analysis of protein secondary structure from circular dichroism.
Anal Biochem. 1993 Feb 15;209(1):32-44. doi: 10.1006/abio.1993.1079.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验